Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Completed 6Unknown 2Recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 2Hemorrhage 2Thrombocytopenia 1Recurrence 1Postoperative Hemorrhage 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Melanoma 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Blood Loss, Surgical 1

Interventions

Tranexamic Acid 2Enoxaparin 2carbetocin 1Tinzaparin 1Solutions 1Sodium Chloride 1Saline Solution 1N(4)-oleylcytosine arabinoside 1Methylergonovine 1Injections, Intravenous 1Ergonovine 1Dalteparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Hemorrhage × Tranexamic Acid × Clear all
NCT06229483 2026-03-19

The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies

Nova Scotia Health Authority

Phase 3 Recruiting
102 enrolled
CNS

Brain Neoplasms, Hemorrhage

NCT06023212 2025-02-10

Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1/2 Recruiting
150 enrolled

Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡